Looking at 2021’s US Food and Drug Administration (FDA) drug approvals, one might not have known there was still a major health crisis underway. More than 50 new drugs were waved through — close to 2018’s all-time high and on a par with those in 2020 (Fig. 1 and Table 1), the first pandemic year. On top of its usual workload, the FDA faced political pressure to accelerate already speedy approval timelines for COVID-19 vaccines and therapeutics… Fonte: Nature Biotechnology | VOL 40 | February 2022 | 155–162 | www.nature.com/naturebiotechnology 155 Para…
2021 FDA approvals
The FDA’s approval count last year was in line with recent trends, despite the continued impact of COVID-19. The agency’s Center for Drug Evaluation and Research (CDER) approved 50 novel therapeutics in 2021, down from 53 in 2020 (Fig. 1; Table 1). The 5-year average sits at 51 drugs per year. A decade ago, it was 24 drugs per year…. Para acessar a publicação na íntegra clique aqui Fonte: Nature Reviews | DRUG DISCOVERY volume 21 | February 2022 | 83…